Intranasal Oxytocin and the exploration of eye gaze in people who stutter.

Phase 2

• Conditions: Stuttering; Mental Health - Anxiety; Mental Health - Other mental health disorders

• Registration Number: ACTRN12611000434998
• Lead Sponsor: niversity of Sydney

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2011-04-27
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: ot yet recruiting
• Sex: Male
• Target Recruitment: 40

Inclusion Criteria

Male adults who stutter

Onset of stuttering before 12 years of age

No treatment for stuttering or anxiety conditions within 6 months preceding the experimental procedure

Exclusion Criteria

Onset of stuttering at age 12 years or older

Onset of stuttering due to a known conversion or any other psychological disorder

Presence of a complicating disorder (e.g., developmental delay, autism, Down’s Syndrome, cerebral palsy etc.)

Currently taking ‘psychological’ medication

Severe Depression with suicidal thoughts and/ or actions

Severe Cardiovascular problems (e.g., heart disease, history of heart attacks)

Kidney Disease- (i.e., kidney stones, recurrent bladder infections, or known kidney failure)

Psychosis (i.e., bizarre beliefs that do not represent reality; sensations without any sensory input- hearing, smelling seeing, feeling things that don’t exist.

Drugs: Smoking more than 15 cigarettes a day or addicted to other illegal substances.

Sensitivity to preservatives (in particular E 216, E 218 and chlorobutanol hemihydrate)

Study & Design

• Study Type: Interventional
• Study Design: Not specified